| abstract |
The present invention relates to the use of β-glycoprotein inhibitory compounds, e.g. R8 is a hydrogen atom or blonde constituents of aromatic rings; R 'is hydrogen or alkyl, R4 is methyl, methylene or ethylene, which forms a ring denoded by one of rings a and b; R5 is hydrogen, hydroxy or alkyl; R6 is hydrogen, alkyl or alkoxy; R9 is optionally substituted phenyl or heterocyclic, with X, oxygen or sulfur, -S- (CH2) p- or -O- (CH2) p-, wherein p = 1-6; Ar is an unsaturated carbocyclic or heterocyclic tube; n and q = 0 or 1; and m = 0 or an integer from 1 to 6 - and pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical or veterinary compositions containing them. ŕ |